Isabela Ribeiro

4.8k total citations
52 papers, 2.1k citations indexed

About

Isabela Ribeiro is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Isabela Ribeiro has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Public Health, Environmental and Occupational Health, 35 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Isabela Ribeiro's work include Trypanosoma species research and implications (29 papers), Research on Leishmaniasis Studies (27 papers) and Malaria Research and Control (10 papers). Isabela Ribeiro is often cited by papers focused on Trypanosoma species research and implications (29 papers), Research on Leishmaniasis Studies (27 papers) and Malaria Research and Control (10 papers). Isabela Ribeiro collaborates with scholars based in Switzerland, Brazil and Argentina. Isabela Ribeiro's co-authors include Lívia de Figueiredo Diniz, Alejandro G. Schijman, Ivo Santana Caldas, Maria Terezinha Bahia, André Talvani, Joaquím Gascón, Faustino Torrico, Ana Lia Mazzeti, Melba Gomes and Isabel Mayer de Andrade and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Isabela Ribeiro

51 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabela Ribeiro Switzerland	27	1.5k	1.4k	464	304	213	52	2.1k
Fernando Salvador Spain	26	1.3k 0.9×	1.2k 0.9×	395 0.9×	764 2.5×	126 0.6×	151	2.4k
Gérardo Priotto Switzerland	20	1.2k 0.8×	1.1k 0.8×	272 0.6×	475 1.6×	123 0.6×	34	1.7k
Áluízio Prata Brazil	28	1.8k 1.2×	1.6k 1.1×	188 0.4×	1.1k 3.5×	208 1.0×	140	3.0k
José A Ruiz-Postigo Switzerland	22	1.1k 0.7×	1.3k 0.9×	106 0.2×	503 1.7×	216 1.0×	35	1.9k
Adrián Sánchez‐Montalvá Spain	23	1.2k 0.8×	1.0k 0.7×	377 0.8×	416 1.4×	119 0.6×	112	2.1k
Max Grögl United States	35	1.7k 1.1×	2.7k 1.9×	449 1.0×	568 1.9×	271 1.3×	76	3.3k
Fabiana Alves Switzerland	26	847 0.6×	2.0k 1.4×	207 0.4×	649 2.1×	83 0.4×	81	2.4k
Carmen Cañavate Spain	36	2.8k 1.9×	4.0k 2.8×	243 0.5×	1.1k 3.6×	270 1.3×	60	4.6k
Jaime Altcheh Argentina	26	2.0k 1.3×	1.4k 1.0×	398 0.9×	454 1.5×	285 1.3×	105	2.3k
María‐Jesús Pinazo Spain	32	2.6k 1.7×	2.0k 1.4×	555 1.2×	663 2.2×	322 1.5×	115	3.2k

Countries citing papers authored by Isabela Ribeiro

Since Specialization

Citations

This map shows the geographic impact of Isabela Ribeiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabela Ribeiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabela Ribeiro more than expected).

Fields of papers citing papers by Isabela Ribeiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabela Ribeiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabela Ribeiro. The network helps show where Isabela Ribeiro may publish in the future.

Co-authorship network of co-authors of Isabela Ribeiro

This figure shows the co-authorship network connecting the top 25 collaborators of Isabela Ribeiro. A scholar is included among the top collaborators of Isabela Ribeiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabela Ribeiro. Isabela Ribeiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goyal, Vishal, Anouk Neven, Vijay Satam, et al.. (2024). Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitis. Clinical and Translational Science. 17(9). e13908–e13908. 1 indexed citations

Goyal, Vishal, Anouk Neven, Stephen Robinson, et al.. (2024). Bioavailability of three novel oral, sustained‐release pellets, relative to an immediate‐release tablet containing 500 mg flucytosine: A randomized, open‐label, crossover study in healthy volunteers. Clinical and Translational Science. 17(3). e13756–e13756. 3 indexed citations

Malavige, Gathsaurie Neelika, Peter Sjö, Kavita Singh, et al.. (2023). Facing the escalating burden of dengue: Challenges and perspectives. SHILAP Revista de lepidopterología. 3(12). e0002598–e0002598. 34 indexed citations

Padilla, Ángel M., Phil Y. Yao, Gretchen Cooley, et al.. (2021). High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA. PLoS neglected tropical diseases. 15(3). e0009141–e0009141. 17 indexed citations

Alvar, Jorge, Fabiana Alves, Bruno Bucheton, et al.. (2020). Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases. Seminars in Immunopathology. 42(3). 231–246. 36 indexed citations

Shroufi, Amir, Tom Chiller, David W. Denning, et al.. (2020). Ending deaths from HIV-related cryptococcal meningitis by 2030. The Lancet Infectious Diseases. 21(1). 16–18. 19 indexed citations

Roberts, Teri, Óscar Bernal, Paul Roddy, et al.. (2020). Prioritising pathogens for the management of severe febrile patients to improve clinical care in low- and middle-income countries. BMC Infectious Diseases. 20(1). 117–117. 2 indexed citations

Watson, James A, et al.. (2019). Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole. Antimicrobial Agents and Chemotherapy. 63(4). 19 indexed citations

Parry, Christopher M., Isabela Ribeiro, Kāmini Walia, et al.. (2019). Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities. BMJ. 364. k5322–k5322. 38 indexed citations

10.

Mazzeti, Ana Lia, Lívia de Figueiredo Diniz, Vanessa Carla Furtado Mosqueira, et al.. (2018). Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study. Biochemical Pharmacology. 148. 213–221. 13 indexed citations

11.

Pinazo, María‐Jesús, M. Carmen Thomas, Jacqueline Búa, et al.. (2014). Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. Expert Review of Anti-infective Therapy. 12(4). 479–496. 79 indexed citations

12.

Requena‐Méndez, Ana, Manuel Carlos López, Andrea Angheben, et al.. (2013). Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review. Expert Review of Anti-infective Therapy. 11(9). 957–976. 36 indexed citations

13.

Duffy, Tomás, Carolina Cura, Juan Carlos Ramı́rez, et al.. (2013). Analytical Performance of a Multiplex Real-Time PCR Assay Using TaqMan Probes for Quantification of Trypanosoma cruzi Satellite DNA in Blood Samples. PLoS neglected tropical diseases. 7(1). e2000–e2000. 204 indexed citations

14.

Bahia, Maria Terezinha, Isabel Mayer de Andrade, Lívia de Figueiredo Diniz, et al.. (2012). Fexinidazole: A Potential New Drug Candidate for Chagas Disease. PLoS neglected tropical diseases. 6(11). e1870–e1870. 143 indexed citations

15.

Caldas, Sérgio, Ivo Santana Caldas, Lívia de Figueiredo Diniz, et al.. (2012). Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection. Acta Tropica. 123(3). 170–177. 67 indexed citations

16.

Kitua, Andrew, Peter I. Folb, Marian Warsame, et al.. (2010). The use of placebo in a trial of rectal artesunate as initial treatment for severe malaria patients en route to referral clinics: ethical issues. Journal of Medical Ethics. 36(2). 116–120. 3 indexed citations

17.

Terlouw, Dianne J., et al.. (2008). Regional Age-Based Dose Regimens for a New Fixed-Dose Combination of Artesunate-Mefloquine for the Treatment of Uncomplicated Falciparum Malaria in Latin America and Asia. American Journal of Tropical Medicine and Hygiene. 79. 216–216. 2 indexed citations

18.

Terlouw, Dianne J., Isabela Ribeiro, Walter R. J. Taylor, Piero Olliaro, & Feiko O. ter Kuile. (2007). Optimized age-based dosing regimens of the new fixed-dose combinations artesunate-amodiaquine and artesunate mefloquine for the treatment of uncomplicated falciparum malaria. Tropical Medicine & International Health. 12. 120–120. 1 indexed citations

19.

Onyebujoh, Philip, Isabela Ribeiro, & Christopher C. Whalen. (2007). Treatment Options for HIV‐Associated Tuberculosis. The Journal of Infectious Diseases. 196(s1). S35–S45. 41 indexed citations

20.

Barnes, Karen I., James Mwenechanya, Madalitso Tembo, et al.. (2004). Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. The Lancet. 363(9421). 1598–1605. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact